SCHEMBL7215580

SCHEMBL7215580

NCC(O)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31298228 0.97 MEN1 (0.39)
SCHEMBL29004067 0.94
SCHEMBL3249614 0.79 DPP7 (0.36)
SCHEMBL6505666 0.77 USP2 (0.43)
SCHEMBL8007596 0.77 MEN1 (0.33)
SCHEMBL3261592 0.74
SCHEMBL12244538 0.74
SCHEMBL13356069 0.74 DPP7 (0.36)
SCHEMBL19523849 0.72
SCHEMBL669829 0.72 MAPT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3406142-B1 SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS CELGENE INT II SARL (CH) 2020-12-23 EP disclosed
US-6624313-B2 Treating the corrresponding 3-protected hydroxypyrrolidine compound with a base in the presence of an alkyl alcohol and isolating the crystalline form WARNER-LAMBERT COMPANY LLC 2003-09-23 US disclosed
US-6624313-B2 Treating the corrresponding 3-protected hydroxypyrrolidine compound with a base in the presence of an alkyl alcohol and isolating the crystalline form WARNER-LAMBERT COMPANY LLC 2003-09-23 US disclosed
US-20020161241-A1 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists PFIZER INC. 2002-10-31 US disclosed
US-20020161241-A1 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists PFIZER INC. 2002-10-31 US disclosed